Abstract
Introduction: The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil.Areas covered: This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed.Expert opinion: This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.
Original language | English (US) |
---|---|
Pages (from-to) | 845-851 |
Number of pages | 7 |
Journal | Expert Opinion on Drug Delivery |
Volume | 12 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2015 |
Keywords
- Microtablet
- Pain
- Sublingual
- Sufentanil
ASJC Scopus subject areas
- Pharmaceutical Science